Thus while the deletions we observed in Barrett's stem cells appeared very similar in numbers and even the genes affected to those seen in EAC35, 36 (Fig. 5e), Barrett's stem cells generally lacked the p53 mutations and interstitial amplifications of receptor tyrosine kinases and other established oncogenes found in these cancers (Fig. 5d). This evidence concerns the gene TP53 and cancer.